Clover Corporation Limited (ASX:CLV)

Market Cap	173.55M +141.7%
Revenue (ttm)	92.50M +27.6%
Net Income	8.89M +99.0%
EPS	0.05 +97.6%
Shares Out	166.07M
PE Ratio	19.64
Forward PE	20.49
Dividend	0.02 (1.91%)
Ex-Dividend Date	Apr 15, 2026

Volume	41,911
Average Volume	125,154
Open	1.045
Previous Close	1.045
Day's Range	1.045 - 1.100
52-Week Range	0.375 - 1.165
Beta	-0.36
RSI	71.70
Earnings Date	Mar 23, 2026

About Clover Corporation

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega’s Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. Clover Corporation Limited was incorporated in 1988 and is headquarte...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1988
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CLV

Financial Performance

In fiscal year 2025, Clover Corporation's revenue was 86.00 million, an increase of 38.25% compared to the previous year's 62.21 million. Earnings were 7.02 million, an increase of 382.46%.